A Study of ES009 in Subjects With Locally Advanced or Metastatic Solid Tumors

NCT06007482 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: ES009

Sponsor

Elpiscience Biopharma Australia Pty. Ltd.